Leadership Overview
WuXi Biologics has 6 executives leading key functions including strategy, technology, finance, human resources, and scientific research.
Driven by innovation, WuXi Biologics provides integrated technology platforms for biologics drug development, fostering advancements in global healthcare through its comprehensive service offerings.
Driven by innovation, WuXi Biologics provides integrated technology platforms for biologics drug development, fostering advancements in global healthcare through its comprehensive service offerings.
Leadership Roles at WuXi Biologics
Jimmy Li - Chief Executive Officer
Jimmy Li, the Chief Executive Officer at WuXi Biologics, directs the overall corporate strategy and operational execution. Overseeing global business development and market expansion, the Chief Executive Officer ensures alignment with the company's mission to accelerate and transform biologics discovery and development. This leadership position involves driving innovation across all business units and fostering strategic partnerships to enhance the company's integrated technology platforms. By optimizing resource allocation and guiding long-term planning, Jimmy Li directly impacts WuXi Biologics' capacity to deliver cutting-edge solutions for its clients worldwide. Ultimately, Li secures the company's competitive advantage and sustained growth in the biopharmaceutical sector.
Ming Tu - Chief Financial Officer
Ming Tu, the Chief Financial Officer at WuXi Biologics, manages all financial operations and strategic fiscal planning. Overseeing accounting, treasury, and investor relations, the Chief Financial Officer ensures robust financial health and transparency. This position is vital for supporting WuXi Biologics' global expansion and ongoing investment in research and development platforms. By optimizing capital allocation and managing financial risks, Ming Tu directly contributes to the company's ability to fund its ambitious growth objectives and deliver value to stakeholders. Tu's financial acumen underpins the company's operational stability and its capacity to pursue strategic opportunities in the biopharmaceutical services market.
Jijie Gu - Chief Scientific Officer, President of Global Biologics Research
Jijie Gu, the Chief Scientific Officer, President of Global Biologics Research at WuXi Biologics, drives the scientific vision and research strategy for biologics discovery. Gu oversees the global research teams, focusing on advancing novel therapeutic modalities and platform technologies. This critical role ensures WuXi Biologics remains at the cutting edge of scientific innovation in the biopharmaceutical industry. By fostering a collaborative research environment and directing key scientific initiatives, Jijie Gu directly contributes to the development of groundbreaking treatments. The Chief Scientific Officer, President of Global Biologics Research's leadership is instrumental in expanding the company's scientific capabilities and supporting client success in bringing complex biologics to market.
Xuejun Gu - Chief Technology Officer
Xuejun Gu, the Chief Technology Officer at WuXi Biologics, architects the company's technological infrastructure and innovation roadmap. Gu oversees the development and implementation of advanced platforms that support biologics drug discovery, development, and manufacturing. This role is critical in ensuring WuXi Biologics maintains its leadership in providing integrated technology solutions. By driving research into novel bioprocessing techniques and digital integration, the Chief Technology Officer enhances operational efficiency and scientific capabilities. Xuejun Gu's strategic vision ensures the company's technological offerings remain at the forefront of the industry, directly supporting client success in bringing life-saving therapies to market.
Sherry Gu - Executive Vice President & Chief Technology Officer
Sherry Gu, the Executive Vice President & Chief Technology Officer at WuXi Biologics, spearheads the advancement of the company's core technology platforms. Gu focuses on enhancing the efficiency and scalability of biologics development processes, ensuring WuXi Biologics remains a leader in the field. This dual role involves both strategic technological direction and operational oversight of key R&D initiatives. By driving the integration of cutting-edge technologies, Sherry Gu directly supports the acceleration of drug candidate pipelines for clients. The Executive Vice President & Chief Technology Officer's expertise is crucial for maintaining WuXi Biologics' competitive edge and its commitment to scientific excellence in biopharmaceutical innovation.
Xiaohui Liu - Chief Human Resources Officer & Executive Vice President
Xiaohui Liu, the Chief Human Resources Officer & Executive Vice President at WuXi Biologics, leads talent acquisition, development, and organizational strategy. Liu is responsible for cultivating a high-performance culture that supports the company's rapid growth and innovation in biologics R&D. This executive position ensures that WuXi Biologics attracts and retains top scientific and operational talent globally. By aligning HR initiatives with business objectives, Xiaohui Liu directly enhances employee engagement and operational effectiveness across all departments. The Chief Human Resources Officer & Executive Vice President's focus on people strategy is fundamental to WuXi Biologics' mission of accelerating drug development and improving patient outcomes.
Explore Leadership Teams in Business Services
Pharmaron engages in discovery, development, and manufacturing spectrum for small molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices and clinic research. The company offers laboratory, clinical development, chemistry manufactory and control, and other services.
Company Leadership
GP
PC
INVAP is a leading Argentine company with 50 years of experience in developing complex technological projects, particularly in nuclear technology, space, defense, and medical systems. They provide innovative solutions that enhance daily life, focusing on applications in health, environmental protection, and security. Their expertise allows them to manage the entire project lifecycle, catering to the needs of both public and private sectors. INVAP aims to improve the quality of life and contribute to sustainable development through their advanced technologies.
Company Leadership GP
AV
BV
NEFCO, headquartered in Rochester, New Hampshire, and established in 1993, is a fire investigation company. Their services include fire scene and explosion investigation, scene inspection, litigation support, and evidence storage.
Company Leadership DE
Sime Darby Industrial Australasia (SDIA) is a leader in the heavy equipment industry in our region. As part of the worlds largest Cat dealer groups, and with an operational footprint that covers Australia, New Zealand, Papua New Guinea, the Solomon Islands, and New Caledonia, SDIA offers industrial solutions that cater to the needs of its customers across various industries. SDIAs core businesses are in the sale and rental of heavy equipment and power systems, providing after-sales product support, and leveraging technology to develop innovative productivity solutions for customers in the resources, construction, power generation, forestry, marine, agriculture, material handling and oil & gas sectors. The group is continuing to grow and strengthen its presence in the market with a number of strategic, value-enhancing acquisitions, providing a base for expansion across the industrial sector in the wider Australasian region.
Company Leadership EA
MS
GB
JC
Frequently Asked Questions Regarding WuXi Biologics Top Executives and Leadership Team
Unlock more people and company data
